New series of advanced freeze dryers
The LyoConstellation series allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation.
SP Scientific has announced the LyoConstellation S10, S20 and S30 as the first in a new series of advanced freeze dryers. All are configured-to-order for faster delivery freeze-drying cycle development and small-scale aseptic production, such as the production of stability batches or early-phase clinical trial batches.
LyoConstellation is a Line of Sight-enabled freeze-drying system with very powerful refrigeration, delivering an expanded equipment capability and a large process space. This allows the development of highly aggressive cycles and the mapping of the furthest reaches of theoretical design space for a formulation. When handling high-value active pharmaceutical ingredient (API), and with a need to bring product to market as quickly and safely as possible, LyoConstellation can address early stage development under aseptic and controlled conditions. This means product behaves in the same manner once it is ready for scale-up and eventually ready for commercialization.
Offering a capacity of 9.8 ft2 (1 m2) and precise shelf temperature control from -55 °C to +65 °C, the LyoConstellation S10 is designed, even when fully loaded, to hold 100mTorr vacuum and shelf temperatures of over +40 °C enabling unmatched sublimation rates with high moisture applications with no evidence of choked flow. Isolator and cleanroom integratable, the LyoConstellation is capable of clean-in-place (CIP) and steam-in-place (SIP) for aseptic manufacturing.
The LyoConstellation series – including the S10, S20 and S30 offering shelf capacities from 9.8 ft2 (1 m2) to 33 ft2 (3 m2) – are all powerfully equipped as standard to provide very high capacity, broaden equipment capability and expand design space. Configurable with the latest technologies including SMART cycle optimization technology, ControLyo Ice Nucleation Technology and LyoFlux TDLAS (Tunable Diode Laser Absorption Spectroscopy) for vapor mass flow measurement and inference of critical data such as batch product temperature and batch Kv (vial heat transfer coefficient), the LyoConstellation is able to deliver an unmatched array of process analytical data. These technology options together with the LyoSTM software platform, for working in compliance with 21 CFR Part 11, are common to the full range of SP Scientific freeze dryers enabling the same technologies and equipment to be used for both R&D and production.
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance